Clearside Biomedical Inc (NAS:CLSD)
$ 1.15 0 (0%) Market Cap: 85.96 Mil Enterprise Value: 57.46 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 64/100

Clearside Biomedical Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 13, 2022 / 07:45PM GMT
Release Date Price: $2.13 (+4.93%)
Serge Belanger
Needham & Company, LLC - Analyst

Good afternoon and welcome to Needham's 21st annual healthcare conference. I'm Serge Belanger, one of the healthcare analysts at Needham. We're happy to have the Clearside Biomedical team with us this afternoon. So from the company, we have Charlie Deignan, the CFO; as well as Tom Ciulla, who is the Chief Medical Officer of the company.

So I'll hand it over to Charlie and Tom to give us an overview of Clearside, and then I think we'll have time for some Q&A at the end. For those listening online, I think you can submit questions via the portal. We'll be looking at those when we move over towards the Q&A portion.

So, gentlemen, the floor is yours.

Tom Ciulla
Clearside Biomedical, Inc. - Chief Medical Officer & Chief Development Officer

Well, thanks for having us, Serge. As a retina specialist, I'm very excited to be part of a potential paradigm shift in the way we deliver retinal therapeutics. Next slide, please.

I'd like to remind you that we may make forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot